Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting267%
unknown133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

NCT07555210
recruiting

The Impact of Glomerular Disorders on Bone Quality and Strength

NCT04528446
unknown

Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)

NCT04181164

Clinical Trials (3)

Showing 3 of 3 trials
NCT07555210Not Applicable

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

Recruiting
NCT04528446

The Impact of Glomerular Disorders on Bone Quality and Strength

Recruiting
NCT04181164

Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3